Top Biotechnology & Medical Research stocks in Australasia

Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.

Name	Market Cap	Price to Earnings TTM	Dividend Yield % TTM
MSBMesoblast	AU$3.05bn	n/a	n/a
TLXTelix Pharmaceuticals	AU$2.96bn	144.1	n/a
PYCPYC Therapeutics	AU$1.41bn	n/a	n/a
CU6Clarity Pharmaceuticals	AU$919.41m	n/a	n/a
IMMImmutep	AU$533.04m	n/a	n/a
RACRacura Oncology	AU$373.55m	n/a	n/a
CGSCogstate	AU$366.57m	26.38	0.86%
DXBDimerix	AU$284.29m	n/a	n/a
PEBPacific Edge	NZ$229.98m	n/a	n/a
TTXTetratherix	AU$186.23m	n/a	n/a
NYRNyrada	AU$166.62m	n/a	n/a
ACWActinogen Medical	AU$130.26m	n/a	n/a
PARParadigm Biopharmaceuticals	AU$116.83m	n/a	n/a
ALAArovella Therapeutics	AU$110.54m	n/a	n/a
BXNBioxyne	AU$103.91m	21.05	n/a
LTPLtr Pharma	AU$93.20m	n/a	n/a
ILAIsland Pharmaceuticals	AU$90.90m	n/a	n/a
CYPCynata Therapeutics	AU$83.60m	n/a	n/a
ATHAlterity Therapeutics	AU$73.02m	n/a	n/a
PIQProteomics International Laboratories	AU$64.59m	n/a	n/a